| Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial S Yokota, T Imagawa, M Mori, T Miyamae, Y Aihara, S Takei, N Iwata, ... The Lancet 371 (9617), 998-1006, 2008 | 1022 | 2008 |
| Therapeutic efficacy of humanized recombinant anti–interleukin‐6 receptor antibody in children with systemic‐onset juvenile idiopathic arthritis S Yokota, T Miyamae, T Imagawa, N Iwata, S Katakura, M Mori, P Woo, ... Arthritis & Rheumatism 52 (3), 818-825, 2005 | 473 | 2005 |
| Follistatin-like protein-1 is a novel proinflammatory molecule T Miyamae, AD Marinov, D Sowders, DC Wilson, J Devlin, R Boudreau, ... The Journal of Immunology 177 (7), 4758-4762, 2006 | 164 | 2006 |
| Hypothetical pathophysiology of acute encephalopathy and encephalitis related to influenza virus infection and hypothermia therapy S Yokota, T Imagawa, T Miyamae, SI Ito, S Nakajima, A Nezu, M Mori Pediatrics International 42 (2), 197-203, 2000 | 143 | 2000 |
| Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis T Imagawa, S Yokota, M Mori, T Miyamae, S Takei, H Imanaka, Y Nerome, ... Modern rheumatology 22 (1), 109-115, 2012 | 119 | 2012 |
| Milk fat globule EGF factor 8 in the serum of human patients of systemic lupus erythematosus H Yamaguchi, J Takagi, T Miyamae, S Yokota, T Fujimoto, S Nakamura, ... Journal of Leucocyte Biology 83 (5), 1300-1307, 2008 | 119 | 2008 |
| Remedies for infant chronic arthritis-relating diseases K Yoshizaki, N Nishimoto, M Iwamoto, S Minota, S Yokota, T Miyamae US Patent App. 10/473,165, 2004 | 111 | 2004 |
| Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series M Mori, T Imagawa, R Hara, M Kikuchi, T Hara, T Nozawa, T Miyamae, ... The Journal of rheumatology 39 (4), 864-867, 2012 | 105 | 2012 |
| Plasma exchange for refractory Kawasaki disease T Imagawa, M Mori, T Miyamae, S Ito, T Nakamura, K Yasui, H Kimura, ... European journal of pediatrics 163, 263-264, 2004 | 100 | 2004 |
| Increased oxidative stress and coenzyme Q10 deficiency in juvenile fibromyalgia: amelioration of hypercholesterolemia and fatigue by ubiquinol-10 supplementation T Miyamae, M Seki, T Naga, S Uchino, H Asazuma, T Yoshida, Y Iizuka, ... Redox Report 18 (1), 12-19, 2013 | 93 | 2013 |
| Longterm safety and effectiveness of the anti-interleukin 6 receptor monoclonal antibody tocilizumab in patients with systemic juvenile idiopathic arthritis in Japan S Yokota, T Imagawa, M Mori, T Miyamae, S Takei, N Iwata, ... The Journal of rheumatology 41 (4), 759-767, 2014 | 92 | 2014 |
| Proteasome inhibition enhances AAV-mediated transgene expression in human synoviocytes in vitro and in vivo K Jennings, T Miyamae, R Traister, A Marinov, S Katakura, D Sowders, ... Molecular Therapy 11 (4), 600-607, 2005 | 92 | 2005 |
| Efficacy of plasma exchange therapy for Kawasaki disease intractable to intravenous gamma-globulin M Mori, T Imagawa, S Katakura, T Miyamae, K Okuyama, S Ito, ... Modern rheumatology 14 (1), 43-47, 2004 | 92 | 2004 |
| Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis M Yanagimachi, T Naruto, T Hara, M Kikuchi, R Hara, T Miyamae, ... British journal of clinical pharmacology 71 (2), 237-243, 2011 | 79 | 2011 |
| Association of IRF5 polymorphisms with susceptibility to macrophage activation syndrome in patients with juvenile idiopathic arthritis M Yanagimachi, T Naruto, T Miyamae, T Hara, M Kikuchi, R Hara, ... The Journal of rheumatology 38 (4), 769-774, 2011 | 78 | 2011 |
| Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis S Yokota, T Miyamae, T Imagawa, S Katakura, R Kurosawa, M Mori Clinical reviews in allergy & immunology 28, 231-237, 2005 | 71 | 2005 |
| Safety and response to influenza vaccine in patients with systemic-onset juvenile idiopathic arthritis receiving tocilizumab T Shinoki, R Hara, U Kaneko, T Miyamae, T Imagawa, M Mori, S Yokota Modern rheumatology 22 (6), 871-876, 2012 | 65 | 2012 |
| Cryopyrin-associated periodic syndromes: diagnosis and management T Miyamae Pediatric Drugs 14, 109-117, 2012 | 63 | 2012 |
| Influence of outdoor NO2 exposure on asthma in childhood: Meta‐analysis Y Takenoue, T Kaneko, T Miyamae, M Mori, S Yokota Pediatrics International 54 (6), 762-769, 2012 | 60 | 2012 |
| Serum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapy T Miyamae, DE Malehorn, B Lemster, M Mori, T Imagawa, S Yokota, ... Arthritis research & therapy 7, 1-10, 2005 | 59 | 2005 |
